Lankenau Heart Institute
Welcome,         Profile    Billing    Logout  
 67 Trials 
138 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Morse, Michael A
COMPOSE, NCT04919226 / 2021-001086-20: Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) -

Active, not recruiting
3
259
Europe, US, RoW
177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT, 177Lu-DOTATOC 177Lu-Edo, CAPTEM (Capecitabine and Temozolomide), Amino-Acid Solution, Arginine-Lysine Solution, Everolimus, FOLFOX (Folinic acid + Fluorouracil + Oxaliplatin)
ITM Solucin GmbH
Neuroendocrine Tumors
06/27
09/27
NCT03632941: A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer

Active, not recruiting
2
8
US
VRP-HER2, AVX901, Pembrolizumab, Keytruda
Herbert Lyerly, Merck Sharp & Dohme LLC
Breast Cancer, HER2+ Breast Cancer
10/23
12/25
ACCRU-GI-2008, NCT05168163: Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

Recruiting
2
122
US
Atezolizumab, MPDL 3280A, MPDL 328OA, MPDL-3280A, MPDL3280A, MPDL328OA, RG7446, RO5541267, Tecentriq, Cabozantinib, Lenvatinib, E7080, ER-203492-00, Multi-Kinase Inhibitor E7080
Academic and Community Cancer Research United, National Cancer Institute (NCI), Genentech, Inc.
Locally Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8, Stage IVA Hepatocellular Carcinoma AJCC v8, Stage IVB Hepatocellular Carcinoma AJCC v8, Unresectable Hepatocellular Carcinoma
12/24
12/26
ELU-FRα-1, NCT05001282: A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

Terminated
1/2
79
US
ELU001, FA-CDC
Elucida Oncology
Ovarian Cancer, Ovarian Neoplasms, Ovarian Carcinoma, Endometrial Cancer, Ovary Cancer, Ovary Neoplasm, Ovary Disease, Ovary Metastasis, Ovarian Diseases, Ovarian Cancer Stage, Ovarian Epithelial Cancer, Ovarian Adenocarcinoma, Ovarian Serous Adenocarcinoma, Ovarian Neoplasm Epithelial, Ovarian Cancer Recurrent, Endometrial Diseases, Endometrial Adenocarcinoma, Endometrial Carcinosarcoma, Endometrial Clear Cell Adenocarcinoma, Endometrioid Adenocarcinoma, Endometrial Neoplasms, Endometrial Cancer Recurrent, Endometrioid Tumor, Fallopian Tube Cancer, Peritoneal Cancer
06/24
06/24
KISIMA-01, NCT04046445: Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer

Active, not recruiting
1
96
Europe, US
ATP128, BI 754091, Ezabenlimab, VSV-GP128
Amal Therapeutics, Boehringer Ingelheim
Colorectal Cancer, MSS, Stage IV Colon Cancer, Stage IV Rectal Cancer, Metastatic Colorectal Cancer, Liver Metastasis Colon Cancer
05/25
08/25
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
06/26
06/31
NCT03735667: ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement

Active, not recruiting
N/A
1948
Canada, US
ACURATE neo2™ Transfemoral TAVR System, Medtronic CoreValve TAVR System, Edwards SAPIEN 3 TAVR System, ACURATE Prime™ Transfemoral TAVR System XL
Boston Scientific Corporation
Aortic Stenosis
06/24
09/34
NCT04482062: TRISCEND II Pivotal Trial

Active, not recruiting
N/A
1070
Europe, US
Edwards EVOQUE System, Transcatheter tricuspid valve replacement, Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases, Cardiovascular Diseases, Heart Failure
12/25
12/29
Ramlawi, Basel
NCT03635424: Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study

Active, not recruiting
N/A
150
US
Medtronic TAVR Systems
Medtronic Cardiovascular
Bicuspid Aortic Valve
11/19
12/30
ReChord, NCT02803957: Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair

Recruiting
N/A
585
US
NeoChord DS1000, Surgical Mitral Valve Repair
NeoChord
Mitral Valve Insufficiency
07/22
07/27
NCT06203054: CLIP-IT Post-Market Study

Active, not recruiting
N/A
150
US
Penditure™ Left Atrial Appendage (LAA) Exclusion System
Medtronic Cardiac Surgery
Left Atrial Appendage Exclusion
11/25
02/29
PERSEVERE, NCT05174767: - a Trial to Evaluate AMDS in Acute DeBakey Type I Dissection

Active, not recruiting
N/A
115
US
AMDS
Artivion Inc., Syneos Health
Acute Aortic Dissection
12/23
12/29
NCT03546374: Medtronic Terminate AF Study

Recruiting
N/A
160
US
Surgical Ablation, Cardioblate and Cryoflex hand held devices
Medtronic Cardiac Surgery
Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation
10/24
12/26
NCT05295628: Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR

Active, not recruiting
N/A
532
US
EMBLOK™ Embolic Protection System ("EMBLOK EPS"), SENTINEL™ Cerebral Protection System
Innovative Cardiovascular Solutions, Yale Cardiovascular Research Group
Aortic Valve Stenosis, Aortic Valve Disease, Aortic Valve Insufficiency, Aortic Valve Replacement
05/25
07/25
RESTORE, NCT06777368: REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Recruiting
N/A
225
US
Medtronic TAV, Edwards TAV
Medtronic Cardiovascular
Aortic Stenosis
03/29
07/33
NCT04198870: MitraClip REPAIR MR Study

Recruiting
N/A
500
Europe, Canada, US
MitraClip™ device implantation, Mitral Valve Repair Surgery
Abbott Medical Devices
Mitral Valve Regurgitation
04/26
04/34
APOLLO, NCT03242642: Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Recruiting
N/A
1056
Europe, Canada, US
Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR)
Medtronic Cardiovascular
Mitral Valve Regurgitation
10/26
09/36
LeAAPS, NCT05478304: Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Recruiting
N/A
6500
Europe, Canada, US, RoW
AtriClip LAA Exclusion System
AtriCure, Inc., Population Health Research Institute
Ischemic Stroke, Systemic Embolism
12/31
04/32
Sievert, Horst
SCOUT-II, NCT03225612: Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)

Recruiting
N/A
60
Europe
Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)
Mitralign, Inc., Genae, Regulatory and Clinical Research Institute Inc, CardioVascular Research Foundation, Korea
Chronic Symptomatic Functional Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Heart Valve Disease
06/18
11/22
NCT03666780: Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up Study

Active, not recruiting
N/A
500
Europe, RoW
LAmbre Occluder
Lifetech Scientific (Shenzhen) Co., Ltd., IQVIA Biotech
Atrial Fibrillation
11/21
09/24
AcChord, NCT04190602: Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System

Recruiting
N/A
500
Europe
NeoChord Artificial Chordae Delivery System, Model DS1000, NeoChord DS1000, DS1000
NeoChord
Mitral Regurgitation, Mitral Valve Disease, Mitral Valve Insufficiency, Mitral Valve Prolapse, Heart Valve Diseases
10/22
12/27
Omega, NCT04829929: Evaluation od Safety and Performance of the ™ LAA (Left Atrial Appendage) Occluder and ™ Delivery System in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk

Recruiting
N/A
150
Europe
Omega™LAA Occluder implantation
Eclipse Medical Ltd., KCRI
Non-Valvular Atrial Fibrillation
05/23
11/23
CAPTURE2, NCT03892824: Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants

Active, not recruiting
N/A
100
Europe, RoW
Vine™ Embolic Protection System
Javelin Medical, Genae
Atrial Fibrillation, Stroke
10/24
10/27
PROOF, NCT04029233: The Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO

Terminated
N/A
582
Europe, Canada
Occlutech PFO Occluder, Occlutech Figulla Flex II Occluder
Occlutech International AB
Stroke, PFO - Patent Foramen Ovale
04/24
04/24
CorCinch-HF, NCT04331769: Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

Recruiting
N/A
400
Europe, US, RoW
AccuCinch Ventricular Restoration System, Guideline-Directed Medical Therapy
Ancora Heart, Inc.
Heart Failure With Reduced Ejection Fraction (HFrEF), Dilated Cardiomyopathy
12/26
12/30
NCT02880631: BAROSTIM THERAPY™ In Resistant Hypertension

Recruiting
N/A
500
Europe
BAROSTIM NEO™ System
CVRx, Inc.
Hypertension
07/24
07/24
CALM-DIEM, NCT02827032: Controlling and Lowering Blood Pressure With the MobiusHD™

Recruiting
N/A
200
Europe
MobiusHD™
Vascular Dynamics, Inc.
Hypertension
12/24
06/26
VECTOR-HF, NCT03775161: V-LAP™ Left Atrium Monitoring systEm for Patients With Chronic sysTOlic & Diastolic Congestive heaRt Failure

Active, not recruiting
N/A
45
Europe
V-LAP™ System, Echocardiography
Vectorious Medical Technologies Ltd., Horizon 2020 - European Commission
Heart Failure
12/26
12/26
NCT05069558: Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

Active, not recruiting
N/A
450
Europe, Canada, US
Investigational PFO Closure Device, Standard of Care PFO Closure Device
Occlutech International AB
Stroke, Patent Foramen Ovale, PFO
11/25
10/26
HF-FIM, NCT04590001: Effect of the MobiusHD® in Patients With Heart Failure

Recruiting
N/A
50
Europe, Canada, RoW
MobiusHD
Vascular Dynamics, Inc.
Heart Failure With Reduced Ejection Fraction
12/25
06/26
NCT05147792: The CONFORM Pivotal Trial

Recruiting
N/A
1600
US, RoW
CLAAS, WATCHMAN left atrial appendage closure device / Amulet left atrial appendage occluder
Conformal Medical, Inc
Atrial Fibrillation, Stroke
06/28
12/31
CLEARANCE, NCT04298723: Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.

Recruiting
N/A
530
Europe
Percutaneous closure of the LAA (Watchman / Watchman FLX)
Jena University Hospital
Atrial Fibrillation (AF), Intracranial Bleed
06/27
06/27
LAAOS-4, NCT05963698: The Fourth Left Atrial Appendage Occlusion Study

Recruiting
N/A
4000
Europe, Canada, US
WATCHMAN device
Hamilton Health Sciences Corporation, McMaster University, Population Health Research Institute, Boston Scientific Corporation
Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism
09/29
12/29
Gray, William K
REGENERATE-PD, NCT06285643: A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease

Recruiting
2
87
Europe, US
AAV2-GDNF Gene therapy, Biological, Control Surgery
AskBio Inc, Bayer
Parkinson Disease
11/27
11/27
CT-AMT-130-02, NCT05243017 / 2020-001461-36: Safety and Efficacy of AMT-130 in European Adults with Early Manifest Huntington's Disease

Active, not recruiting
1/2
14
Europe
intra-striatal rAAV5-miHTT, AMT-130
UniQure Biopharma B.V., uniQure biopharma B.V.
Huntington Disease
03/29
10/29
TRANSCEND, NCT03241459: Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

Completed
N/A
446
Europe, US, RoW
Surmodics SurVeil DCB, Medtronic IN.PACT Admiral DCB
SurModics, Inc.
Peripheral Arterial Disease, Peripheral Vascular Disease, Artery Disease, Peripheral, Femoropopliteal Artery Occlusion
09/20
09/24
ConformalEFS, NCT03616028: The CONFORMAL Early Feasibility Study

Active, not recruiting
N/A
64
US
left atrial appendage closure
Conformal Medical, Inc, Yale Cardiovascular Research Group
Non-valvular Atrial Fibrillation
05/22
06/25
PERFORMANCE II, NCT04201132: Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System

Active, not recruiting
N/A
305
Europe, US, RoW
Carotid artery stenting with Neuroguard IEP System
Contego Medical, Inc., Yale Cardiovascular Research Group, Advance Research Associates, CardioMed Device Consultants, LLC, Iqvia Pty Ltd, Medidata Solutions
Carotid Artery Stenosis, Carotid Artery Diseases, Carotid Stenosis
10/23
12/25
TRIOMPHE, NCT04471909: NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness

Recruiting
N/A
110
US, RoW
NEXUS Aortic Stent Graft System
Endospan Ltd.
Aortic Dissection, Aortic Aneurysm, Intramural Hematoma, Penetrating Aortic Ulcer
07/25
10/29
NCT05653336: PerQseal® Clinical Study

Active, not recruiting
N/A
149
Europe, US
PerQseal® Closure Device System
Vivasure Medical Limited
Percutaneous Large Hole Vascular Closure
12/24
06/25
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
06/26
06/31
NCT04905017: Trisol System EFS Study

Recruiting
N/A
15
US
Transcatheter Tricuspid Valve Replacement
Trisol Medical
Tricuspid Regurgitation
01/25
07/27
NCT04482062: TRISCEND II Pivotal Trial

Active, not recruiting
N/A
1070
Europe, US
Edwards EVOQUE System, Transcatheter tricuspid valve replacement, Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases, Cardiovascular Diseases, Heart Failure
12/25
12/29
NCT06212193: Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)

Recruiting
N/A
15
Europe, US
Trillium™
Innoventric LTD, Innoventric Inc.
Tricuspid Regurgitation, Tricuspid Regurgitation Functional
08/25
08/30
ALT-FLOW II, NCT05686317: Trial of the Edwards APTURE Transcatheter Shunt System

Recruiting
N/A
100
Europe, Canada, US
Edwards APTURE transcatheter shunt system, Sham procedure
Edwards Lifesciences
Heart Failure
01/26
08/30
NCT03523416: Early Feasibility Study - Edwards APTURE Transcatheter Shunt System

Active, not recruiting
N/A
71
US
Transcatheter Atrial Shunt System
Edwards Lifesciences
Heart Failure
12/23
11/28
CLASP II TR, NCT04097145: Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Recruiting
N/A
870
Canada, US
Edwards PASCAL System, Transcatheter tricuspid valve repair (TTVr), Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease
12/27
12/31
NCT03382457: Clinical Study of Edwards Cardioband FIT Valve Repair System

Recruiting
N/A
75
US
Transcatheter Tricuspid Valve Repair, Edwards Cardioband Tricuspid Valve Repair
Edwards Lifesciences
Tricuspid Regurgitation
12/26
12/31
CREST-2, NCT02089217: Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

Active, not recruiting
N/A
2486
Europe, Canada, US, RoW
Carotid endarterectomy (CEA), Carotid Stenting (CAS), Intensive Medical Management - no CEA, Intensive Medical Management - no CAS
Mayo Clinic, National Institute of Neurological Disorders and Stroke (NINDS)
Carotid Stenosis
02/26
02/26
NCT04198870: MitraClip REPAIR MR Study

Recruiting
N/A
500
Europe, Canada, US
MitraClip™ device implantation, Mitral Valve Repair Surgery
Abbott Medical Devices
Mitral Valve Regurgitation
04/26
04/34
NCT05147792: The CONFORM Pivotal Trial

Recruiting
N/A
1600
US, RoW
CLAAS, WATCHMAN left atrial appendage closure device / Amulet left atrial appendage occluder
Conformal Medical, Inc
Atrial Fibrillation, Stroke
06/28
12/31
APOLLO, NCT03242642: Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Recruiting
N/A
1056
Europe, Canada, US
Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR)
Medtronic Cardiovascular
Mitral Valve Regurgitation
10/26
09/36
Goldman, Scott
SITRAL, NCT02830204: Surgical Implantation of TRAnscatheter vaLve in Native Mitral Annular Calcification () Study

Completed
N/A
25
US
Mitral Valve Replacement (MVR) with Sapien3, MVR
Baylor Research Institute, Edwards Lifesciences
Mitral Annular Calcification
01/23
11/23
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
06/26
06/31
NCT04198870: MitraClip REPAIR MR Study

Recruiting
N/A
500
Europe, Canada, US
MitraClip™ device implantation, Mitral Valve Repair Surgery
Abbott Medical Devices
Mitral Valve Regurgitation
04/26
04/34
APOLLO, NCT03242642: Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Recruiting
N/A
1056
Europe, Canada, US
Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR)
Medtronic Cardiovascular
Mitral Valve Regurgitation
10/26
09/36
Dhoble, Abhijeet
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
06/26
06/31
NCT03735667: ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement

Active, not recruiting
N/A
1948
Canada, US
ACURATE neo2™ Transfemoral TAVR System, Medtronic CoreValve TAVR System, Edwards SAPIEN 3 TAVR System, ACURATE Prime™ Transfemoral TAVR System XL
Boston Scientific Corporation
Aortic Stenosis
06/24
09/34
NCT04482062: TRISCEND II Pivotal Trial

Active, not recruiting
N/A
1070
Europe, US
Edwards EVOQUE System, Transcatheter tricuspid valve replacement, Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases, Cardiovascular Diseases, Heart Failure
12/25
12/29
CATALYST, NCT04226547: Amplatzer Amulet LAAO Vs. NOAC

Recruiting
N/A
2650
Europe, Canada, Japan, US, RoW
Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder), Amplatzer Amulet LAA Occluder, Non-Vitamin K Oral Antagonists, NOAC
Abbott Medical Devices
Atrial Fibrillation, Stroke, Bleeding
08/27
08/30
CLASP II TR, NCT04097145: Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Recruiting
N/A
870
Canada, US
Edwards PASCAL System, Transcatheter tricuspid valve repair (TTVr), Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease
12/27
12/31
NCT05295628: Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR

Active, not recruiting
N/A
532
US
EMBLOK™ Embolic Protection System ("EMBLOK EPS"), SENTINEL™ Cerebral Protection System
Innovative Cardiovascular Solutions, Yale Cardiovascular Research Group
Aortic Valve Stenosis, Aortic Valve Disease, Aortic Valve Insufficiency, Aortic Valve Replacement
05/25
07/25
RESTORE, NCT06777368: REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Recruiting
N/A
225
US
Medtronic TAV, Edwards TAV
Medtronic Cardiovascular
Aortic Stenosis
03/29
07/33
NCT05069558: Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

Active, not recruiting
N/A
450
Europe, Canada, US
Investigational PFO Closure Device, Standard of Care PFO Closure Device
Occlutech International AB
Stroke, Patent Foramen Ovale, PFO
11/25
10/26
FROST-HF, NCT05136820: Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study

Active, not recruiting
N/A
698
US
Atrial Flow Regulator, AFR, Sham Comparator
Occlutech International AB
Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Reduced Ejection Fraction (HFrEF)
02/26
02/29
Loyalka, Pranav
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
06/26
06/31
COSIRA-II, NCT05102019: Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

Recruiting
N/A
380
Canada, US
Arm 1: treatment with Shockwave Reducer, Arm 2 (control): Implantation procedure with no device implanted, Arm 3 (unblinded, non-randomized): Single arm registry
Shockwave Medical, Inc., Shockwave Medical, Inc.
Refractory Angina
07/27
01/32
CorCinch-HF, NCT04331769: Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

Recruiting
N/A
400
Europe, US, RoW
AccuCinch Ventricular Restoration System, Guideline-Directed Medical Therapy
Ancora Heart, Inc.
Heart Failure With Reduced Ejection Fraction (HFrEF), Dilated Cardiomyopathy
12/26
12/30
NCT04482062: TRISCEND II Pivotal Trial

Active, not recruiting
N/A
1070
Europe, US
Edwards EVOQUE System, Transcatheter tricuspid valve replacement, Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases, Cardiovascular Diseases, Heart Failure
12/25
12/29
ALT-FLOW II, NCT05686317: Trial of the Edwards APTURE Transcatheter Shunt System

Recruiting
N/A
100
Europe, Canada, US
Edwards APTURE transcatheter shunt system, Sham procedure
Edwards Lifesciences
Heart Failure
01/26
08/30
CATALYST, NCT04226547: Amplatzer Amulet LAAO Vs. NOAC

Recruiting
N/A
2650
Europe, Canada, Japan, US, RoW
Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder), Amplatzer Amulet LAA Occluder, Non-Vitamin K Oral Antagonists, NOAC
Abbott Medical Devices
Atrial Fibrillation, Stroke, Bleeding
08/27
08/30
CLASP II TR, NCT04097145: Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Recruiting
N/A
870
Canada, US
Edwards PASCAL System, Transcatheter tricuspid valve repair (TTVr), Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease
12/27
12/31
NCT05069558: Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

Active, not recruiting
N/A
450
Europe, Canada, US
Investigational PFO Closure Device, Standard of Care PFO Closure Device
Occlutech International AB
Stroke, Patent Foramen Ovale, PFO
11/25
10/26
FROST-HF, NCT05136820: Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study

Active, not recruiting
N/A
698
US
Atrial Flow Regulator, AFR, Sham Comparator
Occlutech International AB
Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Reduced Ejection Fraction (HFrEF)
02/26
02/29
PROTECT IV, NCT04763200: Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

Active, not recruiting
N/A
1252
Europe, Canada, US
Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®, IABP Intra-aortic balloon pump
Abiomed Inc.
Left Ventricular Dysfunction, Coronary Artery Disease
03/26
10/27
NCT04198870: MitraClip REPAIR MR Study

Recruiting
N/A
500
Europe, Canada, US
MitraClip™ device implantation, Mitral Valve Repair Surgery
Abbott Medical Devices
Mitral Valve Regurgitation
04/26
04/34
COMPLETE TAVR, NCT04634240: Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

Recruiting
N/A
4000
Canada, US
Percutaneous Coronary Intervention (PCI)
University of British Columbia
Aortic Stenosis, Coronary Artery Disease, Coronary Stenosis
04/26
04/26
Kar, Biswajit
TRICAV, NCT06137807: TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (-I)

Recruiting
N/A
50
US
TricValve® Transcatheter Bicaval Valve System, TricValve System
P+F Products + Features USA Inc., P+F Products + Features GmbH, Meditrial USA Inc.
Tricuspid Regurgitation, Tricuspid Valve Disease
11/25
09/29
CLASP II TR, NCT04097145: Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Recruiting
N/A
870
Canada, US
Edwards PASCAL System, Transcatheter tricuspid valve repair (TTVr), Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease
12/27
12/31
Jordan, Jennifer H
NCT05932732: Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.

Completed
4
27
US
HydraFacial Syndeo System, ReGen-GF, HydraFacial Elite MD System
Austin Institute for Clinical Research, The HydraFacial Company
Cutis Laxa Facialis, Xeroderma
10/24
10/24
NCT06090071: Trial Evaluating Both Tolerability and Improvement for Signs of Facial Photoaging, Discoloration, and Texture in Adult Females of All Skin Types by Combining a Placebo Moisturizer and Non-ablative Laser.

Completed
4
38
US
LaseMD Laser, Sciton Laser, Phyto A+ Brightening Treatment
Austin Institute for Clinical Research, SkinCeuticals
Photoaging
09/24
09/24
EDGI, NCT04378101: Eating Disorders Genetics Initiative

Completed
N/A
17991
US, RoW
Eating disorder diagnosis group
University of North Carolina, Chapel Hill, National Institute of Mental Health (NIMH), University of Otago, University of Aarhus, QIMR Berghofer Medical Research Institute
Anorexia Nervosa, Bulimia Nervosa, Binge-Eating Disorder
05/23
05/23
NCT03191461: Myocardial Perfusion and Fibrosis in Cancer Survivors

Completed
N/A
7
US
Adenosine stress test MRI, MRI, Stress Test
Virginia Commonwealth University, Wake Forest University
Myocardial Fibrosis, Myocardial Injury, Chemotherapeutic Toxicity
04/24
04/24
EDGI2, NCT06594913: Eating Disorders Genetics Initiative 2

Recruiting
N/A
20000
Europe, US, RoW
Eating disorder diagnosis group
University of North Carolina, Chapel Hill, Queensland Institute of Medical Research, Karolinska Institutet, National Institute of Mental Health (NIMH), University of Otago, University of Aarhus, Yale University, Comenzar de Nuevo A.C., University of Sydney
Anorexia Nervosa, Bulimia Nervosa, Binge-Eating Disorder, Avoidant Restrictive Food Intake Disorder
08/27
08/27
CROWN, NCT05309655: Cardiac Outcomes With Near-Complete Estrogen Deprivation

Recruiting
N/A
90
US
Adenosine Stress Cardiac Magnetic Resonance Imaging, Electrocardiogram, Computed Tomography Angiogram, Laboratory Testing, Quality of Life Survey
Duke University, National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI)
Breast Cancer, Triple Negative Breast Cancer, Cardiovascular Complications
12/25
12/27
NCT04502316: Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)

Active, not recruiting
N/A
5000
US
Barostim™ System
CVRx, Inc.
Heart Failure
06/28
06/28
Chikowski, Ann Marie
NCT05163548: PerQseal®+ Early Feasibility Study

Completed
N/A
15
US
PerQseal Plus Device, Vascular Closure Device
Vivasure Medical Limited
Percutaneous Large Hole Vascular Closure
07/22
07/22
NCT04905017: Trisol System EFS Study

Recruiting
N/A
15
US
Transcatheter Tricuspid Valve Replacement
Trisol Medical
Tricuspid Regurgitation
01/25
07/27
NCT04943172: The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis Study

Active, not recruiting
N/A
75
US
Hancock-Jaffe bioprosthetic venous valve (VenoValve®)
Hancock Jaffe Laboratiores, Inc, AXIOM Real Time Metrics, Syntactx
Deep Venous Insufficiency (Diagnosis)
10/24
03/28
Coady, Paul
NCT05653336: PerQseal® Clinical Study

Active, not recruiting
N/A
149
Europe, US
PerQseal® Closure Device System
Vivasure Medical Limited
Percutaneous Large Hole Vascular Closure
12/24
06/25
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
06/26
06/31
Rodriguez, Roberto
NCT04557462 / 2020-002200-40: A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Recruiting
3
540
Europe, Canada, Japan, US, RoW
LNP023, iptacopan
Novartis Pharmaceuticals, Novartis Pharma AG
Primary IgA Nephropathy
11/32
11/32
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
06/26
06/31
VISION I, NCT04289935: Intelligent Vacuum Assisted Biopsy Immediately Before Surgery As an Intra- or Pre-Operative Surrogate for Patient Response to Neoadjuvant Chemotherapy for Breast Cancer

Recruiting
N/A
420
Europe, RoW
Vacuum assisted biopsy (VAB)
Klinik Hirslanden, Zurich, Oncoplastic Breast Consortium (OPBC)
Breast Cancer
06/25
06/25
Eads, Kristin
NCT05562934: An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.

Completed
2
191
Europe, Japan, US, RoW
XXB750 drug, Placebo
Novartis Pharmaceuticals
Resistant Hypertension
07/24
08/24
NCT05198674: SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Recruiting
N/A
1400
Europe, US, RoW
Renal Denervation (Symplicity Spyral™), Renal Angiography, Renal Denervation
Medtronic Vascular
Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus
11/26
11/29

Recruiting
N/A
1857
US
WATCHMAN FLX Pro LAAC Device, WATCHMAN FLX Pro Left Atrial Appendage Closure Device
Boston Scientific Corporation
Atrial Fibrillation, Stroke, Bleeding
07/26
01/27
NCT05147792: The CONFORM Pivotal Trial

Recruiting
N/A
1600
US, RoW
CLAAS, WATCHMAN left atrial appendage closure device / Amulet left atrial appendage occluder
Conformal Medical, Inc
Atrial Fibrillation, Stroke
06/28
12/31
Al-Amoodi, Mohammed
CLASP II TR, NCT04097145: Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Recruiting
N/A
870
Canada, US
Edwards PASCAL System, Transcatheter tricuspid valve repair (TTVr), Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease
12/27
12/31
Silva, Guilherme
PORTICO IDE, NCT02000115: Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial

Active, not recruiting
N/A
1242
US, RoW
Portico transcatheter aortic valve, Commercially available transcatheter aortic valve
Abbott Medical Devices
Aortic Valve Stenosis
10/19
07/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Morse, Michael A
COMPOSE, NCT04919226 / 2021-001086-20: Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) -

Active, not recruiting
3
259
Europe, US, RoW
177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT, 177Lu-DOTATOC 177Lu-Edo, CAPTEM (Capecitabine and Temozolomide), Amino-Acid Solution, Arginine-Lysine Solution, Everolimus, FOLFOX (Folinic acid + Fluorouracil + Oxaliplatin)
ITM Solucin GmbH
Neuroendocrine Tumors
06/27
09/27
NCT03632941: A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer

Active, not recruiting
2
8
US
VRP-HER2, AVX901, Pembrolizumab, Keytruda
Herbert Lyerly, Merck Sharp & Dohme LLC
Breast Cancer, HER2+ Breast Cancer
10/23
12/25
ACCRU-GI-2008, NCT05168163: Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

Recruiting
2
122
US
Atezolizumab, MPDL 3280A, MPDL 328OA, MPDL-3280A, MPDL3280A, MPDL328OA, RG7446, RO5541267, Tecentriq, Cabozantinib, Lenvatinib, E7080, ER-203492-00, Multi-Kinase Inhibitor E7080
Academic and Community Cancer Research United, National Cancer Institute (NCI), Genentech, Inc.
Locally Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8, Stage IVA Hepatocellular Carcinoma AJCC v8, Stage IVB Hepatocellular Carcinoma AJCC v8, Unresectable Hepatocellular Carcinoma
12/24
12/26
ELU-FRα-1, NCT05001282: A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

Terminated
1/2
79
US
ELU001, FA-CDC
Elucida Oncology
Ovarian Cancer, Ovarian Neoplasms, Ovarian Carcinoma, Endometrial Cancer, Ovary Cancer, Ovary Neoplasm, Ovary Disease, Ovary Metastasis, Ovarian Diseases, Ovarian Cancer Stage, Ovarian Epithelial Cancer, Ovarian Adenocarcinoma, Ovarian Serous Adenocarcinoma, Ovarian Neoplasm Epithelial, Ovarian Cancer Recurrent, Endometrial Diseases, Endometrial Adenocarcinoma, Endometrial Carcinosarcoma, Endometrial Clear Cell Adenocarcinoma, Endometrioid Adenocarcinoma, Endometrial Neoplasms, Endometrial Cancer Recurrent, Endometrioid Tumor, Fallopian Tube Cancer, Peritoneal Cancer
06/24
06/24
KISIMA-01, NCT04046445: Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer

Active, not recruiting
1
96
Europe, US
ATP128, BI 754091, Ezabenlimab, VSV-GP128
Amal Therapeutics, Boehringer Ingelheim
Colorectal Cancer, MSS, Stage IV Colon Cancer, Stage IV Rectal Cancer, Metastatic Colorectal Cancer, Liver Metastasis Colon Cancer
05/25
08/25
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
06/26
06/31
NCT03735667: ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement

Active, not recruiting
N/A
1948
Canada, US
ACURATE neo2™ Transfemoral TAVR System, Medtronic CoreValve TAVR System, Edwards SAPIEN 3 TAVR System, ACURATE Prime™ Transfemoral TAVR System XL
Boston Scientific Corporation
Aortic Stenosis
06/24
09/34
NCT04482062: TRISCEND II Pivotal Trial

Active, not recruiting
N/A
1070
Europe, US
Edwards EVOQUE System, Transcatheter tricuspid valve replacement, Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases, Cardiovascular Diseases, Heart Failure
12/25
12/29
Ramlawi, Basel
NCT03635424: Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study

Active, not recruiting
N/A
150
US
Medtronic TAVR Systems
Medtronic Cardiovascular
Bicuspid Aortic Valve
11/19
12/30
ReChord, NCT02803957: Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair

Recruiting
N/A
585
US
NeoChord DS1000, Surgical Mitral Valve Repair
NeoChord
Mitral Valve Insufficiency
07/22
07/27
NCT06203054: CLIP-IT Post-Market Study

Active, not recruiting
N/A
150
US
Penditure™ Left Atrial Appendage (LAA) Exclusion System
Medtronic Cardiac Surgery
Left Atrial Appendage Exclusion
11/25
02/29
PERSEVERE, NCT05174767: - a Trial to Evaluate AMDS in Acute DeBakey Type I Dissection

Active, not recruiting
N/A
115
US
AMDS
Artivion Inc., Syneos Health
Acute Aortic Dissection
12/23
12/29
NCT03546374: Medtronic Terminate AF Study

Recruiting
N/A
160
US
Surgical Ablation, Cardioblate and Cryoflex hand held devices
Medtronic Cardiac Surgery
Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation
10/24
12/26
NCT05295628: Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR

Active, not recruiting
N/A
532
US
EMBLOK™ Embolic Protection System ("EMBLOK EPS"), SENTINEL™ Cerebral Protection System
Innovative Cardiovascular Solutions, Yale Cardiovascular Research Group
Aortic Valve Stenosis, Aortic Valve Disease, Aortic Valve Insufficiency, Aortic Valve Replacement
05/25
07/25
RESTORE, NCT06777368: REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Recruiting
N/A
225
US
Medtronic TAV, Edwards TAV
Medtronic Cardiovascular
Aortic Stenosis
03/29
07/33
NCT04198870: MitraClip REPAIR MR Study

Recruiting
N/A
500
Europe, Canada, US
MitraClip™ device implantation, Mitral Valve Repair Surgery
Abbott Medical Devices
Mitral Valve Regurgitation
04/26
04/34
APOLLO, NCT03242642: Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Recruiting
N/A
1056
Europe, Canada, US
Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR)
Medtronic Cardiovascular
Mitral Valve Regurgitation
10/26
09/36
LeAAPS, NCT05478304: Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Recruiting
N/A
6500
Europe, Canada, US, RoW
AtriClip LAA Exclusion System
AtriCure, Inc., Population Health Research Institute
Ischemic Stroke, Systemic Embolism
12/31
04/32
Sievert, Horst
SCOUT-II, NCT03225612: Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)

Recruiting
N/A
60
Europe
Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)
Mitralign, Inc., Genae, Regulatory and Clinical Research Institute Inc, CardioVascular Research Foundation, Korea
Chronic Symptomatic Functional Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Heart Valve Disease
06/18
11/22
NCT03666780: Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up Study

Active, not recruiting
N/A
500
Europe, RoW
LAmbre Occluder
Lifetech Scientific (Shenzhen) Co., Ltd., IQVIA Biotech
Atrial Fibrillation
11/21
09/24
AcChord, NCT04190602: Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System

Recruiting
N/A
500
Europe
NeoChord Artificial Chordae Delivery System, Model DS1000, NeoChord DS1000, DS1000
NeoChord
Mitral Regurgitation, Mitral Valve Disease, Mitral Valve Insufficiency, Mitral Valve Prolapse, Heart Valve Diseases
10/22
12/27
Omega, NCT04829929: Evaluation od Safety and Performance of the ™ LAA (Left Atrial Appendage) Occluder and ™ Delivery System in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk

Recruiting
N/A
150
Europe
Omega™LAA Occluder implantation
Eclipse Medical Ltd., KCRI
Non-Valvular Atrial Fibrillation
05/23
11/23
CAPTURE2, NCT03892824: Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants

Active, not recruiting
N/A
100
Europe, RoW
Vine™ Embolic Protection System
Javelin Medical, Genae
Atrial Fibrillation, Stroke
10/24
10/27
PROOF, NCT04029233: The Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO

Terminated
N/A
582
Europe, Canada
Occlutech PFO Occluder, Occlutech Figulla Flex II Occluder
Occlutech International AB
Stroke, PFO - Patent Foramen Ovale
04/24
04/24
CorCinch-HF, NCT04331769: Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

Recruiting
N/A
400
Europe, US, RoW
AccuCinch Ventricular Restoration System, Guideline-Directed Medical Therapy
Ancora Heart, Inc.
Heart Failure With Reduced Ejection Fraction (HFrEF), Dilated Cardiomyopathy
12/26
12/30
NCT02880631: BAROSTIM THERAPY™ In Resistant Hypertension

Recruiting
N/A
500
Europe
BAROSTIM NEO™ System
CVRx, Inc.
Hypertension
07/24
07/24
CALM-DIEM, NCT02827032: Controlling and Lowering Blood Pressure With the MobiusHD™

Recruiting
N/A
200
Europe
MobiusHD™
Vascular Dynamics, Inc.
Hypertension
12/24
06/26
VECTOR-HF, NCT03775161: V-LAP™ Left Atrium Monitoring systEm for Patients With Chronic sysTOlic & Diastolic Congestive heaRt Failure

Active, not recruiting
N/A
45
Europe
V-LAP™ System, Echocardiography
Vectorious Medical Technologies Ltd., Horizon 2020 - European Commission
Heart Failure
12/26
12/26
NCT05069558: Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

Active, not recruiting
N/A
450
Europe, Canada, US
Investigational PFO Closure Device, Standard of Care PFO Closure Device
Occlutech International AB
Stroke, Patent Foramen Ovale, PFO
11/25
10/26
HF-FIM, NCT04590001: Effect of the MobiusHD® in Patients With Heart Failure

Recruiting
N/A
50
Europe, Canada, RoW
MobiusHD
Vascular Dynamics, Inc.
Heart Failure With Reduced Ejection Fraction
12/25
06/26
NCT05147792: The CONFORM Pivotal Trial

Recruiting
N/A
1600
US, RoW
CLAAS, WATCHMAN left atrial appendage closure device / Amulet left atrial appendage occluder
Conformal Medical, Inc
Atrial Fibrillation, Stroke
06/28
12/31
CLEARANCE, NCT04298723: Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.

Recruiting
N/A
530
Europe
Percutaneous closure of the LAA (Watchman / Watchman FLX)
Jena University Hospital
Atrial Fibrillation (AF), Intracranial Bleed
06/27
06/27
LAAOS-4, NCT05963698: The Fourth Left Atrial Appendage Occlusion Study

Recruiting
N/A
4000
Europe, Canada, US
WATCHMAN device
Hamilton Health Sciences Corporation, McMaster University, Population Health Research Institute, Boston Scientific Corporation
Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism
09/29
12/29
Gray, William K
REGENERATE-PD, NCT06285643: A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease

Recruiting
2
87
Europe, US
AAV2-GDNF Gene therapy, Biological, Control Surgery
AskBio Inc, Bayer
Parkinson Disease
11/27
11/27
CT-AMT-130-02, NCT05243017 / 2020-001461-36: Safety and Efficacy of AMT-130 in European Adults with Early Manifest Huntington's Disease

Active, not recruiting
1/2
14
Europe
intra-striatal rAAV5-miHTT, AMT-130
UniQure Biopharma B.V., uniQure biopharma B.V.
Huntington Disease
03/29
10/29
TRANSCEND, NCT03241459: Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

Completed
N/A
446
Europe, US, RoW
Surmodics SurVeil DCB, Medtronic IN.PACT Admiral DCB
SurModics, Inc.
Peripheral Arterial Disease, Peripheral Vascular Disease, Artery Disease, Peripheral, Femoropopliteal Artery Occlusion
09/20
09/24
ConformalEFS, NCT03616028: The CONFORMAL Early Feasibility Study

Active, not recruiting
N/A
64
US
left atrial appendage closure
Conformal Medical, Inc, Yale Cardiovascular Research Group
Non-valvular Atrial Fibrillation
05/22
06/25
PERFORMANCE II, NCT04201132: Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System

Active, not recruiting
N/A
305
Europe, US, RoW
Carotid artery stenting with Neuroguard IEP System
Contego Medical, Inc., Yale Cardiovascular Research Group, Advance Research Associates, CardioMed Device Consultants, LLC, Iqvia Pty Ltd, Medidata Solutions
Carotid Artery Stenosis, Carotid Artery Diseases, Carotid Stenosis
10/23
12/25
TRIOMPHE, NCT04471909: NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness

Recruiting
N/A
110
US, RoW
NEXUS Aortic Stent Graft System
Endospan Ltd.
Aortic Dissection, Aortic Aneurysm, Intramural Hematoma, Penetrating Aortic Ulcer
07/25
10/29
NCT05653336: PerQseal® Clinical Study

Active, not recruiting
N/A
149
Europe, US
PerQseal® Closure Device System
Vivasure Medical Limited
Percutaneous Large Hole Vascular Closure
12/24
06/25
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
06/26
06/31
NCT04905017: Trisol System EFS Study

Recruiting
N/A
15
US
Transcatheter Tricuspid Valve Replacement
Trisol Medical
Tricuspid Regurgitation
01/25
07/27
NCT04482062: TRISCEND II Pivotal Trial

Active, not recruiting
N/A
1070
Europe, US
Edwards EVOQUE System, Transcatheter tricuspid valve replacement, Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases, Cardiovascular Diseases, Heart Failure
12/25
12/29
NCT06212193: Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)

Recruiting
N/A
15
Europe, US
Trillium™
Innoventric LTD, Innoventric Inc.
Tricuspid Regurgitation, Tricuspid Regurgitation Functional
08/25
08/30
ALT-FLOW II, NCT05686317: Trial of the Edwards APTURE Transcatheter Shunt System

Recruiting
N/A
100
Europe, Canada, US
Edwards APTURE transcatheter shunt system, Sham procedure
Edwards Lifesciences
Heart Failure
01/26
08/30
NCT03523416: Early Feasibility Study - Edwards APTURE Transcatheter Shunt System

Active, not recruiting
N/A
71
US
Transcatheter Atrial Shunt System
Edwards Lifesciences
Heart Failure
12/23
11/28
CLASP II TR, NCT04097145: Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Recruiting
N/A
870
Canada, US
Edwards PASCAL System, Transcatheter tricuspid valve repair (TTVr), Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease
12/27
12/31
NCT03382457: Clinical Study of Edwards Cardioband FIT Valve Repair System

Recruiting
N/A
75
US
Transcatheter Tricuspid Valve Repair, Edwards Cardioband Tricuspid Valve Repair
Edwards Lifesciences
Tricuspid Regurgitation
12/26
12/31
CREST-2, NCT02089217: Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

Active, not recruiting
N/A
2486
Europe, Canada, US, RoW
Carotid endarterectomy (CEA), Carotid Stenting (CAS), Intensive Medical Management - no CEA, Intensive Medical Management - no CAS
Mayo Clinic, National Institute of Neurological Disorders and Stroke (NINDS)
Carotid Stenosis
02/26
02/26
NCT04198870: MitraClip REPAIR MR Study

Recruiting
N/A
500
Europe, Canada, US
MitraClip™ device implantation, Mitral Valve Repair Surgery
Abbott Medical Devices
Mitral Valve Regurgitation
04/26
04/34
NCT05147792: The CONFORM Pivotal Trial

Recruiting
N/A
1600
US, RoW
CLAAS, WATCHMAN left atrial appendage closure device / Amulet left atrial appendage occluder
Conformal Medical, Inc
Atrial Fibrillation, Stroke
06/28
12/31
APOLLO, NCT03242642: Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Recruiting
N/A
1056
Europe, Canada, US
Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR)
Medtronic Cardiovascular
Mitral Valve Regurgitation
10/26
09/36
Goldman, Scott
SITRAL, NCT02830204: Surgical Implantation of TRAnscatheter vaLve in Native Mitral Annular Calcification () Study

Completed
N/A
25
US
Mitral Valve Replacement (MVR) with Sapien3, MVR
Baylor Research Institute, Edwards Lifesciences
Mitral Annular Calcification
01/23
11/23
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
06/26
06/31
NCT04198870: MitraClip REPAIR MR Study

Recruiting
N/A
500
Europe, Canada, US
MitraClip™ device implantation, Mitral Valve Repair Surgery
Abbott Medical Devices
Mitral Valve Regurgitation
04/26
04/34
APOLLO, NCT03242642: Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Recruiting
N/A
1056
Europe, Canada, US
Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR)
Medtronic Cardiovascular
Mitral Valve Regurgitation
10/26
09/36
Dhoble, Abhijeet
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
06/26
06/31
NCT03735667: ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement

Active, not recruiting
N/A
1948
Canada, US
ACURATE neo2™ Transfemoral TAVR System, Medtronic CoreValve TAVR System, Edwards SAPIEN 3 TAVR System, ACURATE Prime™ Transfemoral TAVR System XL
Boston Scientific Corporation
Aortic Stenosis
06/24
09/34
NCT04482062: TRISCEND II Pivotal Trial

Active, not recruiting
N/A
1070
Europe, US
Edwards EVOQUE System, Transcatheter tricuspid valve replacement, Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases, Cardiovascular Diseases, Heart Failure
12/25
12/29
CATALYST, NCT04226547: Amplatzer Amulet LAAO Vs. NOAC

Recruiting
N/A
2650
Europe, Canada, Japan, US, RoW
Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder), Amplatzer Amulet LAA Occluder, Non-Vitamin K Oral Antagonists, NOAC
Abbott Medical Devices
Atrial Fibrillation, Stroke, Bleeding
08/27
08/30
CLASP II TR, NCT04097145: Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Recruiting
N/A
870
Canada, US
Edwards PASCAL System, Transcatheter tricuspid valve repair (TTVr), Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease
12/27
12/31
NCT05295628: Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR

Active, not recruiting
N/A
532
US
EMBLOK™ Embolic Protection System ("EMBLOK EPS"), SENTINEL™ Cerebral Protection System
Innovative Cardiovascular Solutions, Yale Cardiovascular Research Group
Aortic Valve Stenosis, Aortic Valve Disease, Aortic Valve Insufficiency, Aortic Valve Replacement
05/25
07/25
RESTORE, NCT06777368: REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Recruiting
N/A
225
US
Medtronic TAV, Edwards TAV
Medtronic Cardiovascular
Aortic Stenosis
03/29
07/33
NCT05069558: Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

Active, not recruiting
N/A
450
Europe, Canada, US
Investigational PFO Closure Device, Standard of Care PFO Closure Device
Occlutech International AB
Stroke, Patent Foramen Ovale, PFO
11/25
10/26
FROST-HF, NCT05136820: Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study

Active, not recruiting
N/A
698
US
Atrial Flow Regulator, AFR, Sham Comparator
Occlutech International AB
Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Reduced Ejection Fraction (HFrEF)
02/26
02/29
Loyalka, Pranav
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
06/26
06/31
COSIRA-II, NCT05102019: Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

Recruiting
N/A
380
Canada, US
Arm 1: treatment with Shockwave Reducer, Arm 2 (control): Implantation procedure with no device implanted, Arm 3 (unblinded, non-randomized): Single arm registry
Shockwave Medical, Inc., Shockwave Medical, Inc.
Refractory Angina
07/27
01/32
CorCinch-HF, NCT04331769: Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study

Recruiting
N/A
400
Europe, US, RoW
AccuCinch Ventricular Restoration System, Guideline-Directed Medical Therapy
Ancora Heart, Inc.
Heart Failure With Reduced Ejection Fraction (HFrEF), Dilated Cardiomyopathy
12/26
12/30
NCT04482062: TRISCEND II Pivotal Trial

Active, not recruiting
N/A
1070
Europe, US
Edwards EVOQUE System, Transcatheter tricuspid valve replacement, Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases, Cardiovascular Diseases, Heart Failure
12/25
12/29
ALT-FLOW II, NCT05686317: Trial of the Edwards APTURE Transcatheter Shunt System

Recruiting
N/A
100
Europe, Canada, US
Edwards APTURE transcatheter shunt system, Sham procedure
Edwards Lifesciences
Heart Failure
01/26
08/30
CATALYST, NCT04226547: Amplatzer Amulet LAAO Vs. NOAC

Recruiting
N/A
2650
Europe, Canada, Japan, US, RoW
Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder), Amplatzer Amulet LAA Occluder, Non-Vitamin K Oral Antagonists, NOAC
Abbott Medical Devices
Atrial Fibrillation, Stroke, Bleeding
08/27
08/30
CLASP II TR, NCT04097145: Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Recruiting
N/A
870
Canada, US
Edwards PASCAL System, Transcatheter tricuspid valve repair (TTVr), Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease
12/27
12/31
NCT05069558: Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

Active, not recruiting
N/A
450
Europe, Canada, US
Investigational PFO Closure Device, Standard of Care PFO Closure Device
Occlutech International AB
Stroke, Patent Foramen Ovale, PFO
11/25
10/26
FROST-HF, NCT05136820: Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study

Active, not recruiting
N/A
698
US
Atrial Flow Regulator, AFR, Sham Comparator
Occlutech International AB
Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Reduced Ejection Fraction (HFrEF)
02/26
02/29
PROTECT IV, NCT04763200: Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

Active, not recruiting
N/A
1252
Europe, Canada, US
Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®, IABP Intra-aortic balloon pump
Abiomed Inc.
Left Ventricular Dysfunction, Coronary Artery Disease
03/26
10/27
NCT04198870: MitraClip REPAIR MR Study

Recruiting
N/A
500
Europe, Canada, US
MitraClip™ device implantation, Mitral Valve Repair Surgery
Abbott Medical Devices
Mitral Valve Regurgitation
04/26
04/34
COMPLETE TAVR, NCT04634240: Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

Recruiting
N/A
4000
Canada, US
Percutaneous Coronary Intervention (PCI)
University of British Columbia
Aortic Stenosis, Coronary Artery Disease, Coronary Stenosis
04/26
04/26
Kar, Biswajit
TRICAV, NCT06137807: TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (-I)

Recruiting
N/A
50
US
TricValve® Transcatheter Bicaval Valve System, TricValve System
P+F Products + Features USA Inc., P+F Products + Features GmbH, Meditrial USA Inc.
Tricuspid Regurgitation, Tricuspid Valve Disease
11/25
09/29
CLASP II TR, NCT04097145: Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Recruiting
N/A
870
Canada, US
Edwards PASCAL System, Transcatheter tricuspid valve repair (TTVr), Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease
12/27
12/31
Jordan, Jennifer H
NCT05932732: Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.

Completed
4
27
US
HydraFacial Syndeo System, ReGen-GF, HydraFacial Elite MD System
Austin Institute for Clinical Research, The HydraFacial Company
Cutis Laxa Facialis, Xeroderma
10/24
10/24
NCT06090071: Trial Evaluating Both Tolerability and Improvement for Signs of Facial Photoaging, Discoloration, and Texture in Adult Females of All Skin Types by Combining a Placebo Moisturizer and Non-ablative Laser.

Completed
4
38
US
LaseMD Laser, Sciton Laser, Phyto A+ Brightening Treatment
Austin Institute for Clinical Research, SkinCeuticals
Photoaging
09/24
09/24
EDGI, NCT04378101: Eating Disorders Genetics Initiative

Completed
N/A
17991
US, RoW
Eating disorder diagnosis group
University of North Carolina, Chapel Hill, National Institute of Mental Health (NIMH), University of Otago, University of Aarhus, QIMR Berghofer Medical Research Institute
Anorexia Nervosa, Bulimia Nervosa, Binge-Eating Disorder
05/23
05/23
NCT03191461: Myocardial Perfusion and Fibrosis in Cancer Survivors

Completed
N/A
7
US
Adenosine stress test MRI, MRI, Stress Test
Virginia Commonwealth University, Wake Forest University
Myocardial Fibrosis, Myocardial Injury, Chemotherapeutic Toxicity
04/24
04/24
EDGI2, NCT06594913: Eating Disorders Genetics Initiative 2

Recruiting
N/A
20000
Europe, US, RoW
Eating disorder diagnosis group
University of North Carolina, Chapel Hill, Queensland Institute of Medical Research, Karolinska Institutet, National Institute of Mental Health (NIMH), University of Otago, University of Aarhus, Yale University, Comenzar de Nuevo A.C., University of Sydney
Anorexia Nervosa, Bulimia Nervosa, Binge-Eating Disorder, Avoidant Restrictive Food Intake Disorder
08/27
08/27
CROWN, NCT05309655: Cardiac Outcomes With Near-Complete Estrogen Deprivation

Recruiting
N/A
90
US
Adenosine Stress Cardiac Magnetic Resonance Imaging, Electrocardiogram, Computed Tomography Angiogram, Laboratory Testing, Quality of Life Survey
Duke University, National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI)
Breast Cancer, Triple Negative Breast Cancer, Cardiovascular Complications
12/25
12/27
NCT04502316: Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)

Active, not recruiting
N/A
5000
US
Barostim™ System
CVRx, Inc.
Heart Failure
06/28
06/28
Chikowski, Ann Marie
NCT05163548: PerQseal®+ Early Feasibility Study

Completed
N/A
15
US
PerQseal Plus Device, Vascular Closure Device
Vivasure Medical Limited
Percutaneous Large Hole Vascular Closure
07/22
07/22
NCT04905017: Trisol System EFS Study

Recruiting
N/A
15
US
Transcatheter Tricuspid Valve Replacement
Trisol Medical
Tricuspid Regurgitation
01/25
07/27
NCT04943172: The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis Study

Active, not recruiting
N/A
75
US
Hancock-Jaffe bioprosthetic venous valve (VenoValve®)
Hancock Jaffe Laboratiores, Inc, AXIOM Real Time Metrics, Syntactx
Deep Venous Insufficiency (Diagnosis)
10/24
03/28
Coady, Paul
NCT05653336: PerQseal® Clinical Study

Active, not recruiting
N/A
149
Europe, US
PerQseal® Closure Device System
Vivasure Medical Limited
Percutaneous Large Hole Vascular Closure
12/24
06/25
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
06/26
06/31
Rodriguez, Roberto
NCT04557462 / 2020-002200-40: A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Recruiting
3
540
Europe, Canada, Japan, US, RoW
LNP023, iptacopan
Novartis Pharmaceuticals, Novartis Pharma AG
Primary IgA Nephropathy
11/32
11/32
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
06/26
06/31
VISION I, NCT04289935: Intelligent Vacuum Assisted Biopsy Immediately Before Surgery As an Intra- or Pre-Operative Surrogate for Patient Response to Neoadjuvant Chemotherapy for Breast Cancer

Recruiting
N/A
420
Europe, RoW
Vacuum assisted biopsy (VAB)
Klinik Hirslanden, Zurich, Oncoplastic Breast Consortium (OPBC)
Breast Cancer
06/25
06/25
Eads, Kristin
NCT05562934: An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.

Completed
2
191
Europe, Japan, US, RoW
XXB750 drug, Placebo
Novartis Pharmaceuticals
Resistant Hypertension
07/24
08/24
NCT05198674: SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Recruiting
N/A
1400
Europe, US, RoW
Renal Denervation (Symplicity Spyral™), Renal Angiography, Renal Denervation
Medtronic Vascular
Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus
11/26
11/29

Recruiting
N/A
1857
US
WATCHMAN FLX Pro LAAC Device, WATCHMAN FLX Pro Left Atrial Appendage Closure Device
Boston Scientific Corporation
Atrial Fibrillation, Stroke, Bleeding
07/26
01/27
NCT05147792: The CONFORM Pivotal Trial

Recruiting
N/A
1600
US, RoW
CLAAS, WATCHMAN left atrial appendage closure device / Amulet left atrial appendage occluder
Conformal Medical, Inc
Atrial Fibrillation, Stroke
06/28
12/31
Al-Amoodi, Mohammed
CLASP II TR, NCT04097145: Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Recruiting
N/A
870
Canada, US
Edwards PASCAL System, Transcatheter tricuspid valve repair (TTVr), Optimal Medical Therapy
Edwards Lifesciences
Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease
12/27
12/31
Silva, Guilherme
PORTICO IDE, NCT02000115: Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial

Active, not recruiting
N/A
1242
US, RoW
Portico transcatheter aortic valve, Commercially available transcatheter aortic valve
Abbott Medical Devices
Aortic Valve Stenosis
10/19
07/25
 

Download Options